These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 16977650)
1. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650 [TBL] [Abstract][Full Text] [Related]
2. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627 [TBL] [Abstract][Full Text] [Related]
3. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS Breast J; 2007; 13(3):251-7. PubMed ID: 17461899 [TBL] [Abstract][Full Text] [Related]
4. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases. Han JS; Molberg KH; Sarode V Breast J; 2011; 17(3):223-9. PubMed ID: 21545433 [TBL] [Abstract][Full Text] [Related]
5. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952 [TBL] [Abstract][Full Text] [Related]
6. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Wilkie C; White L; Dupont E; Cantor A; Cox CE Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920 [TBL] [Abstract][Full Text] [Related]
7. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346 [TBL] [Abstract][Full Text] [Related]
8. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955 [TBL] [Abstract][Full Text] [Related]
9. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy. Tan JC; McCready DR; Easson AM; Leong WL Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256 [TBL] [Abstract][Full Text] [Related]
10. The role of sentinel node biopsy in ductal carcinoma in situ of the breast. Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312 [TBL] [Abstract][Full Text] [Related]
11. Ductal carcinoma in situ: value of sentinel lymph node biopsy. Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457 [TBL] [Abstract][Full Text] [Related]
12. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ. Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854 [TBL] [Abstract][Full Text] [Related]
14. Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy. Schulz S; Sinn P; Golatta M; Rauch G; Junkermann H; Schuetz F; Sohn C; Heil J Breast; 2013 Aug; 22(4):537-42. PubMed ID: 23237921 [TBL] [Abstract][Full Text] [Related]
15. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma. Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S Breast J; 2008; 14(1):55-60. PubMed ID: 18186866 [TBL] [Abstract][Full Text] [Related]
16. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy. Park HS; Park S; Cho J; Park JM; Kim SI; Park BW J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901 [TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy for localised ductal carcinoma in situ? Veronesi P; Intra M; Vento AR; Naninato P; Caldarella P; Paganelli G; Viale G Breast; 2005 Dec; 14(6):520-2. PubMed ID: 16185871 [TBL] [Abstract][Full Text] [Related]
18. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy. Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G Breast J; 2008; 14(2):135-40. PubMed ID: 18315691 [TBL] [Abstract][Full Text] [Related]
19. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797 [TBL] [Abstract][Full Text] [Related]
20. The use of sentinel lymph node biopsy in ductal carcinoma in situ. Schneider C; Trocha S; McKinley B; Shaw J; Bielby S; Blackhurst D; Jones Y; Cornett W Am Surg; 2010 Sep; 76(9):943-6. PubMed ID: 20836339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]